CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Tough-to-Treat leukemia
Disease control Not yet recruitingThis study is testing a drug called asciminib in children and teenagers (ages 1 to under 18) with a specific type of chronic blood cancer called Philadelphia-positive chronic myeloid leukemia (CML). The goal is to see if the drug is safe and effective for kids, including those ne…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for leukemia patients out of treatment options
Disease control Not yet recruitingThis study is testing a new drug called TGRX-678 for adults with chronic phase chronic myeloid leukemia (CML) who have not responded well to or could not tolerate at least three standard treatments. The trial will compare TGRX-678 against other standard leukemia drugs chosen by d…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE3 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC